secwatch.observer — SEC 8-K summary
======================================

Issuer:     enVVeno Medical Corp (NVNO)
CIK:        0001661053
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001493152-25-027482
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

enVVeno stockholders reject 2025 equity plan; authorize reverse stock split
---------------------------------------------------------------------------

- Elected Jenusaitis (3.47M for, 1.80M withheld) and Berman (4.73M for, 0.54M withheld) as Class II directors.
- Advisory say-on-pay passed: 3.19M for, 1.96M against, 5.79M broker non-votes.
- Stockholders voted AGAINST the 2025 Equity Incentive Plan (2.48M for, 2.62M against); 2016 plan remains.
- Approved reverse stock split authorization (7.31M for, 1.58M against) at ratio of 1:5 to 1:35 at Board discretion.
- Ratified CBIZ CPAs P.C. as auditor for FY2025 (10.86M for, 0.14M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661053/000149315225027482/0001493152-25-027482-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661053/000149315225027482/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027482

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer